ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 154,51
0,39%
Dow Jones
43 428,02
-1,69%
DAX
22 287,56
-0,24%
Brent Oil
73,935
0,00%
Bitcoin
96 129,36
-0,46%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Liquidia Corporation (LQDA) Cours

Liquidia Corporation

Liquidia Corporation (LQDA)

iShares USD Corp Bond UCITS ETF
Is $ Crp Bd Ac
16,115
-0,385
(-2,33%)
Fermé 23 Février 10:00PM
Retardé de 15 minutes
16,11
-0,005
(-0,03%)
Après les heures de négociation: 1:29AM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
16,11
Prix Achat
16,11
Prix Vente
20,00
Volume échangé
575 073
16,10 Fourchette du Jour 16,7384
8,26 Plage de 52 semaines 16,99
Cap du marché
1,363B
Clôture Veille
16,50
Ouverture
16,72
Dernière Transaction
1000
@
16.11
(formt)
Dernière heure de transaction
Volume financier
US$ 9 457 373
VWAP
16,4455
Volume moyen (3 m)
814 759
Actions en circulation
84 636 621
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-17,37
Bénéfice par action (BPA)
-0,93
Chiffre d'affairess
17,49M
Bénéfice net
-78,5M

À propos de Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and... Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Pharmaceutical Preparations
Site Web
www.liquidia.com
Siège social
Wilmington, Delaware, USA
Fondé
2004
Liquidia Corporation est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker LQDA. Le dernier cours de clôture d'Liquidia était de US$16,50. Au cours de la dernière année, les actions de Liquidia ont été négociées dans une fourchette de prix de US$ 8,26 à US$ 16,99.

Liquidia compte actuellement 84 636 621 actions en circulation. La capitalisation boursière d'Liquidia est de US$1,40 milliard. Liquidia a un ratio cours/bénéfice (ratio PE) de -17.37.

LQDA Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
23 Janvier 2025
LQDA (-2,33%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 Janvier 2025
LQDA (-2,33%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 Janvier 2025
LQDA (-2,33%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 Janvier 2025
LQDA (-2,33%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 Décembre 2024
LQDA (-2,33%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 Décembre 2024
LQDA (-2,33%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 Novembre 2024
LQDA (-2,33%)

Form 8-K - Current report
Edgar (US Regulatory)
13 Novembre 2024
LQDA (-2,33%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.16-0.98340503995116.2716.8115.9354469616.4338004CS
41.7812.421493370614.3316.8113.775156515.33331117CS
124.4838.521066208111.6316.8110.3781475912.92185167CS
266.5468.33855799379.5716.818.7588242911.36721828CS
522.0914.90727532114.0216.998.2691964912.09197555CS
15610.8203.3898305085.3116.993.268967708.72312067CS
26010.84205.692599625.2716.992.257791697.21885753CS

LQDA - Frequently Asked Questions (FAQ)

What is the current Liquidia share price?
The current share price of Liquidia is US$ 16,11
How many Liquidia shares are in issue?
Liquidia has 84 636 621 shares in issue
What is the market cap of Liquidia?
The market capitalisation of Liquidia is USD 1,4B
What is the 1 year trading range for Liquidia share price?
Liquidia has traded in the range of US$ 8,26 to US$ 16,99 during the past year
What is the PE ratio of Liquidia?
The price to earnings ratio of Liquidia is -17,37
What is the cash to sales ratio of Liquidia?
The cash to sales ratio of Liquidia is 77,98
What is the reporting currency for Liquidia?
Liquidia reports financial results in USD
What is the latest annual turnover for Liquidia?
The latest annual turnover of Liquidia is USD 17,49M
What is the latest annual profit for Liquidia?
The latest annual profit of Liquidia is USD -78,5M
What is the registered address of Liquidia?
The registered address for Liquidia is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Liquidia website address?
The website address for Liquidia is www.liquidia.com
Which industry sector does Liquidia operate in?
Liquidia operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MLGOMicroAlgo Inc
US$ 6,3767
(454,50%)
531,54M
BOXLBoxlight Corporation
US$ 3,1099
(51,70%)
1,84M
GDEVGDEV Inc
US$ 20,90
(46,56%)
264,44k
IVVDInvivyd Inc
US$ 1,7501
(44,64%)
37,75M
UPCUniverse Pharmaceuticals Inc
US$ 0,2003
(40,56%)
420,21M
DOYUDouYu International Holdings Ltd
US$ 7,19
(-55,31%)
1,28M
MNDRMobile health Network Solutions
US$ 0,5048
(-46,29%)
18,61M
BLUEbluebird bio Inc
US$ 4,09
(-41,90%)
5,44M
FLDFold Holdings Inc
US$ 6,95
(-37,39%)
488,54k
GCLGCL Global Holdings Ltd
US$ 3,83
(-31,48%)
635,26k
MLGOMicroAlgo Inc
US$ 6,3767
(454,50%)
531,54M
UPCUniverse Pharmaceuticals Inc
US$ 0,2003
(40,56%)
420,21M
ADTXAditxt Inc
US$ 0,0922
(-22,39%)
278,25M
NVDANVIDIA Corporation
US$ 134,43
(-4,05%)
228,15M
HOLOMicroCloud Hologram Inc
US$ 1,565
(31,51%)
190,81M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
LQDA
Liquidia
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces